Reducing inappropriate, anticholinergic and psychotropic drugs among older residents in assisted living facilities: Study protocol for a randomized controlled trial

Trials

Volumn 13, Issue , 2012, Pages

  Pitkala, Kaisu H ^a   Juola, Anna Liisa ^a,b   Soini, Helena ^c   Laakkonen, Marja Liisa ^a,d   Kautiainen, Hannu ^e   Teramura Gronblad, Mariko ^f   Finne Soveri, Harriet ^g   Bjorkman, Mikko ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b Kuusankoski Health Center   (Finland)

^c Occupational Health Center   (Finland)

^d Laakso Hospital   (Finland)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

^f Helsinki City Health Center   (Finland)

^g NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Anticholinergic drugs; Assisted living; Drug drug interactions; Inappropriate drugs; Polypharmacy; Psychotropic drugs; Randomized controlled trial; Serviced housing

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; PSYCHOTROPIC AGENT;

ARTICLE; ASSISTED LIVING FACILITY; CLINICAL ASSESSMENT; CONSULTATION; CONTROLLED STUDY; DRUG UTILIZATION; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; NURSE; NURSING EDUCATION; OUTCOME ASSESSMENT; PATIENT CARE; QUALITY OF LIFE; RESIDENCY EDUCATION; RESIDENT; TEACHER;

AGE FACTORS; AGED; ASSISTED LIVING FACILITIES; CHOLINERGIC ANTAGONISTS; CLINICAL PROTOCOLS; COGNITION; COST-BENEFIT ANALYSIS; DRUG INTERACTIONS; FINLAND; GERIATRIC ASSESSMENT; HEALTH CARE COSTS; HEALTH SERVICES; HOMES FOR THE AGED; HUMANS; INAPPROPRIATE PRESCRIBING; INSERVICE TRAINING; NEUROPSYCHOLOGICAL TESTS; NURSING STAFF; POLYPHARMACY; PSYCHOTROPIC DRUGS; QUALITY OF LIFE; RESEARCH DESIGN;

EID: 84872227881     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-13-85     Document Type: Article

References (46)

1. Hosia-Randell HM, Muurinen SM, Pitkälä KH. Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study. Drugs Aging 2008, 25:683-692. 10.2165/00002512-200825080-00005, 18665660.
2. Olsson J, Bergman A, Carlsten A, Oké T, Bernsten C, Schmidt IK, Fastbom J. Quality of drug prescribing in elderly people in nursing homes and special care units for dementia: a cross-sectional computerized pharmacy register analysis. Clin Drug Investig 2010, 30:289-300. 10.2165/11534320-000000000-00000, 20384385.
3. Onder G, Liperoti R, Fialova D, Topinkova E, Tosato M, Danese P, Gallo PF, Carpenter I, Finne-Soveri H, Gindin J, Bernabei R, Landi F. SHELTER project: polypharmacy in nursing home in Europe: results from the shelter study. J Gerontol A Biol Sci Med Sci 2012, 67A:698-704.
4. Hosia-Randell H, Pitkälä K. Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs Ageing 2005, 22:793-800.
5. Field TS, Gurwitz JH, Avorn J, McCormick D, Jain S, Eckler M, Benser M, Bates DW. Risk factors for adverse drug events among nursing home residents. Arch Intern Med 2001, 161:1629-1634. 10.1001/archinte.161.13.1629, 11434795.
6. Hanlon JT, Schmader KE, Ruby CM, Weinberger M. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001, 49:200-209. 10.1046/j.1532-5415.2001.49042.x, 11207875.
7. Socialstyrelsen Indikatorer för god läkemedelsterapi hos äldre. Artikelnr 2010, 6:29. [http://www.socialstyrelsen.se/publikationer2010/2010-6-29] Accessed 29 February 2012, Socialstyrelsen.
8. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991, 151:1825-832.
9. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003, 163:2716-2724. 10.1001/archinte.163.22.2716, 14662625.
10. McLeod PJ, Huang AR, Tamblyn RM, Gayton DC. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. Can Med Assoc J 1997, 156:385-391.
11. Gallagher P, O'Mahony D. STOPP (Screening tool of older persons' potentially inappropriate prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing 2008, 37:673-679. 10.1093/ageing/afn197, 18829684.
12. Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, Hanlon JT. Appropriate prescribing in elderly people: how well can it be measured and optimised?. Lancet 2007, 370:173-184. 10.1016/S0140-6736(07)61091-5, 17630041.
13. Raivio MM, Laurila JV, Strandberg TE, Tilvis RS, Pitkala KH. Use of inappropriate medications and their prognostic significance in hospital and nursing home patients with and without dementia in Finland. Drugs Aging 2006, 23:333-343. 10.2165/00002512-200623040-00006, 16732692.
14. Lau DT, Kasper JD, Potter DE, Lyles A. Potentially inappropriate medication prescriptions among elderly nursing home residents: their scope and associated resident and facility characteristics. Health Serv Res 2004, 39:1257-1276. 10.1111/j.1475-6773.2004.00289.x, 1361069, 15333108.
15. Stafford AC, Alswayan MS, Tenni PC. Inappropriate prescribing in older residents of Australian care homes. J Clin Pharm Ther 2011, 36:33-44. 10.1111/j.1365-2710.2009.01151.x, 21198718.
16. Jano E, Aparasu RR. Healthcare outcomes associated with Beers' criteria: a systematic review. Ann Pharmacother 2007, 41:438-447. 10.1345/aph.1H473, 17311835.
17. Borson S, Doane K. The impact of OBRA-87 on psychotropic drug prescribing in skilled nursing facilities. Psychiatr Serv 1997, 48:1289-1296.
18. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005, 294:1934-1943. 10.1001/jama.294.15.1934, 16234500.
19. Wang PS, Schneeweiss S, Avorn J, Fischer MA, Mogun H, Solomon DH, Brookhart MA. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005, 353:2335-2341. 10.1056/NEJMoa052827, 16319382.
20. Hartikainen S, Lönnroos E, Louhivuori K. Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci 2007, 62:1172-1181. 10.1093/gerona/62.10.1172, 17921433.
21. Ancelin ML, Artero S, Portet F, Dupuy AM, Touchon J, Ritchie K. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 2006, 332:455-9. 10.1136/bmj.38740.439664.DE, 1382539, 16452102.
22. Uusvaara J, Pitkala KH, Tienari PJ, Kautiainen H, Tilvis RS, Strandberg TE. Association between anticholinergic drugs and apolipoprotein e ε4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study. J Am Geriatr Soc 2009, 57:427-431. 10.1111/j.1532-5415.2008.02129.x, 19278396.
23. Uusvaara J, Pitkala KH, Kautiainen H, Tilvis RS, Strandberg TE. Association of anticholinergic drugs with hospitalization and mortality among older cardiovascular patients: a prospective study. Drugs Aging 2011, 28:131-138. 10.2165/11585060-000000000-00000, 21275438.
24. Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med 2008, 168:508-513. 10.1001/archinternmed.2007.106, 18332297.
25. Bell S, Strandberg TE, Teramura-Gronblad M, Laurila JV, Tilvis RS, Pitkala KH. Use of proton-pump inhibitors and mortality among institutionalized older people. Arch Intern Med 2010, 170:1604-1605. 10.1001/archinternmed.2010.304, 20876414.
26. Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf 2007, 30:911-918. 10.2165/00002018-200730100-00009, 17867728.
27. SFINX - Lääkeaineiden yhteisvaikutukset (Swedish, Finnish, INteraction X-referencing). [http://www.terveysportti.fi/terveysportti/ia_yhteisvaikutus.koti] Accessed 29 February 2012.
28. Forsetlund L, Eike MC, Gjerberg E, Vist GE. Effect of interventions to reduce potentially inappropriate use of drugs in nursing homes: a systematic review of randomised controlled trials. BMC Geriatr 2011, 11:16. 10.1186/1471-2318-11-16, 3108292, 21496345.
29. Avorn J, Soumerai SB, Everitt DE, Ross-Degnan D, Beers MH, Sherman D, Salem-Schatz SR, Fields D. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med 1992, 327:168-173. 10.1056/NEJM199207163270306, 1608408.
30. Meador KG, Taylor JA, Thapa PB, Fought RL, Ray WA. Predictors of antipsychotic withdrawal or dose reduction in a randomized controlled trial of provider education. J Am Geriatr Soc 1997, 45:207-210.
31. Fossey J, Ballard C, Juszczak E, James I, Alder N, Jacoby R, Howard R. Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial. BMJ 2006, 332:756-761. 10.1136/bmj.38782.575868.7C, 1420717, 16543297.
32. Crotty M, Halbert J, Rowett D, Giles L, Birks R, Williams H, Whitehead C. An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing. Age Ageing 2004, 33:612-617. 10.1093/ageing/afh213, 15385274.
33. Patterson SM, Hughes CM, Crealey G, Cardwell C, Lapane KL. An evaluation of an adapted U.S. model of pharmaceutical care to improve psychoactive prescribing for nursing home residents in Northern Ireland (Fleetwood Northern Ireland study). J Am Geriatr Soc 2010, 58:44-53. 10.1111/j.1532-5415.2009.02617.x, 20002510.
34. Roberts MS, Stokes JA, King MA, Lynne TA, Purdie DM, Glasziou PP, Wilson DA, McCarthy ST, Brooks GE, de Looze FJ, Del Mar CB. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol 2001, 51:257-265. 2015028, 11298072.
35. Crotty M, Rowett D, Spurling L, Giles LC, Phillips PA. Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother 2004, 2:257-264. 10.1016/j.amjopharm.2005.01.001, 15903284.
36. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198. 10.1016/0022-3956(75)90026-6, 1202204.
37. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982, 140:566-572. 10.1192/bjp.140.6.566, 7104545.
38. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C. The consortium to establish a registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989, 39:1159-1165. 10.1212/WNL.39.9.1159, 2771064.
39. Welsh K, Butters N, Hughes J, Mohs R, Heyman A. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol 1991, 48:278-281. 10.1001/archneur.1991.00530150046016, 2001185.
40. Sunderland T. Hill JL, Mellow AM, Lawlor BA, Gundersheimer J, Newhouse PA. Grafman JH: Clock drawing in Alzheimer's disease. A novel measure of dementia severity. J Am Geriatr Soc 1989, 37:725-729.
41. Guigoz Y, Lauque S. Vellas BJ: Identifying the elderly at risk for malnutrition. The Mini Nutritional Assessment. Clin Geriatr Med 2002, 18:737-757.
42. Routasalo PE, Tilvis RS, Kautiainen H, Pitkala KH. Effects of psychosocial group rehabilitation on social functioning, loneliness and well-being of lonely, older people: randomized controlled trial. J Adv Nurs 2009, 65:297-305. 10.1111/j.1365-2648.2008.04837.x, 19054177.
43. Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med 2001, 33:328-336. 10.3109/07853890109002086, 11491191.
44. WHO Collaborating Centre for Drug Statistics Methodology Anatomical therapeutic chemical classification system. ATC/DDD Index 2012. [http://www.whocc.no/atc_ddd_index/] Accessed 1 March 2012, WHO Collaborating Centre for Drug Statistics Methodology.
45. Morris JN, Fries BE, Bernabei R, Ikegami R, Carpenter I, Gilgen R, DuPasquier J, Frijters D, Henrard J, Hirdes JP, Belleville-Taylor P. RAI-home care (RAI-HC) assessment manual for version 2.0 2000, Marblehead, MA: Opus Communications.
46. Leikola S. Development and application of comprehensive medication review procedure to community-dwelling elderly. Dissertationes Biocentri Viikki Universitatis Helsingiensis. Helsinki University Printing House 2012, 48:65. Helsinki, Finland.